このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Lincoln Pharmaceuticals 過去の業績
過去 基準チェック /56
Lincoln Pharmaceuticalsは、平均年間12.5%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間17% 9.1%収益成長率で 成長しています。 Lincoln Pharmaceuticalsの自己資本利益率は15.7%であり、純利益率は16.1%です。
主要情報
12.5%
収益成長率
12.5%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 9.1% |
| 株主資本利益率 | 15.7% |
| ネット・マージン | 16.1% |
| 前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?
Oct 23Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year
Oct 05Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why
Sep 18収支内訳
収支内訳
Lincoln Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 5,805 | 933 | 1,029 | 0 |
| 31 Dec 23 | 5,505 | 873 | 1,066 | 0 |
| 30 Sep 23 | 5,378 | 808 | 1,036 | 0 |
| 30 Jun 23 | 5,225 | 769 | 967 | 0 |
| 31 Mar 23 | 5,103 | 729 | 981 | 0 |
| 31 Dec 22 | 5,004 | 714 | 1,050 | 0 |
| 30 Sep 22 | 4,866 | 674 | 948 | 0 |
| 30 Jun 22 | 4,734 | 667 | 741 | 0 |
| 31 Mar 22 | 4,721 | 694 | 852 | 0 |
| 31 Dec 21 | 4,491 | 709 | 852 | 0 |
| 30 Sep 21 | 4,440 | 668 | 819 | 0 |
| 30 Jun 21 | 4,426 | 647 | 648 | 0 |
| 31 Mar 21 | 4,242 | 623 | 757 | 0 |
| 31 Dec 20 | 4,231 | 586 | 710 | 0 |
| 30 Sep 20 | 4,068 | 560 | 715 | 0 |
| 30 Jun 20 | 3,935 | 540 | 563 | 0 |
| 31 Mar 20 | 3,865 | 514 | 756 | 0 |
| 31 Dec 19 | 3,873 | 510 | 706 | 0 |
| 30 Sep 19 | 3,733 | 492 | 711 | 0 |
| 30 Jun 19 | 3,632 | 453 | 536 | 0 |
| 31 Mar 19 | 3,661 | 487 | 667 | 0 |
| 31 Dec 18 | 3,542 | 470 | 675 | 0 |
| 30 Sep 18 | 3,238 | 495 | 679 | 0 |
| 30 Jun 18 | 3,109 | 458 | 535 | 0 |
| 31 Mar 18 | 3,606 | 346 | 662 | 0 |
| 31 Dec 17 | 4,463 | 281 | 550 | 0 |
| 30 Sep 17 | 4,364 | 231 | 507 | 0 |
| 30 Jun 17 | 4,063 | 206 | 497 | 0 |
| 31 Mar 17 | 3,603 | 281 | 506 | 0 |
| 31 Dec 16 | 3,650 | 301 | 522 | 0 |
| 30 Sep 16 | 3,995 | 301 | 490 | 0 |
| 30 Jun 16 | 4,245 | 281 | 332 | 0 |
| 31 Mar 16 | 4,002 | 237 | 371 | 0 |
| 31 Dec 15 | 3,504 | 219 | 552 | 0 |
| 30 Sep 15 | 3,100 | 180 | 524 | 0 |
| 30 Jun 15 | 2,926 | 183 | 494 | 0 |
| 31 Mar 15 | 2,661 | 150 | 235 | 0 |
| 31 Dec 14 | 2,545 | 135 | 420 | 0 |
| 30 Sep 14 | 2,420 | 142 | 422 | 0 |
| 30 Jun 14 | 2,181 | 106 | 184 | 0 |
| 31 Mar 14 | 2,107 | 107 | 428 | 0 |
| 31 Dec 13 | 2,011 | 140 | 428 | 0 |
| 30 Sep 13 | 2,002 | 122 | 432 | 0 |
| 30 Jun 13 | 2,020 | 121 | 183 | 0 |
質の高い収益: LINCOLNは 高品質の収益 を持っています。
利益率の向上: LINCOLNの現在の純利益率 (16.1%)は、昨年(14.3%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: LINCOLNの収益は過去 5 年間で年間12.5%増加しました。
成長の加速: LINCOLNの過去 1 年間の収益成長率 ( 28% ) は、5 年間の平均 ( 年間12.5%を上回っています。
収益対業界: LINCOLNの過去 1 年間の収益成長率 ( 28% ) はPharmaceuticals業界18%を上回りました。
株主資本利益率
高いROE: LINCOLNの 自己資本利益率 ( 15.7% ) は 低い とみなされます。